Scientists from UC Davis Center for Surgical Bioengineering, the MIND Institute and UC Berkeley’s Murthy Lab are developing ...

The cell and gene therapy sector has never lacked attention, but all too often, the narrative swings from one extreme to ...

The company has made more than 50 deals for its proprietary technology as it looks forward to a potentially “transformative” ...

Two of Opus's seven gene therapy assets are in clinical trials, with additional programs expected to enter the clinic.

The new method is designed to focus specifically on pain-related signals, without interfering with normal activity in other ...

A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the ...

Impella, which J&J touts as the world’s smallest heart pump, has a range of devices used for various heart conditions. Lexeo ...

The MarketWatch News Department was not involved in the creation of this content. PHILADELPHIA and LONDON, Dec. 18, 2025 /PRNewswire/ -- Minaris, a global cell and gene therapy (CGT) contract ...

Gene editing is already being used to treat a handful of rare genetic diseases; however, most therapies involve breaking or inactivating genes. Precisely fixing disease-causing mutations is far more ...

A Yale research team has created a new computer tool that can pinpoint when exactly genes turn on and off over time during brain development - a finding that may one day help doctors identify the ...

Over the last four years, Shriners Children’s St. Louis researchers have been working to develop a new way to prevent the effects of childhood obesity. Now, using gene therapy, Shriners Children’s St.

Nitin Joshi, PhD, and Jingjing Gao, PhD, of the Department of Anesthesiology at Mass General Brigham, are the co-senior ...